QXO, Inc.
QXO
$14.99
+2.81%
QXO, Inc. is a publicly traded distributor of building products in North America, operating in the industrial distribution sector. The company aims to become the tech-enabled leader in the approximately $800 billion building products distribution industry through a strategy of accretive acquisitions and organic growth. Investor attention is currently focused on QXO's transformative $17 billion acquisition of TopBuild, a deal that promises massive revenue growth but raises concerns about integration risks and near-term dilution. The stock has also been under pressure due to broader market volatility and skepticism about its ability to execute on its ambitious $50 billion revenue target within a decade.…
QXO
QXO, Inc.
$14.99
Related headlines
Investment Opinion: Should I buy QXO Today?
Rating: Hold. The thesis is that QXO offers significant upside potential from the TopBuild acquisition, but the risks of integration, persistent losses, and extreme stock volatility warrant caution. The consensus analyst rating is Buy with an average target price implying 189% upside, but the stock's technical and fundamental weakness suggests waiting for a better entry point or confirmation of execution.
Supporting Evidence: QXO's forward PS ratio of 0.33 is a 59% discount to the industry average of 0.8, suggesting undervaluation if revenue targets are met. Revenue grew 147.8% YoY in Q4 2025, driven by acquisitions. The company has a strong current ratio of 3.58 and low debt-to-equity of 0.40. However, the trailing PS of 1.73 is a 116% premium to peers, and the company is unprofitable with a net margin of -4.1%. The stock's 46.5% monthly decline and beta of 2.201 indicate extreme risk.
Risks & Conditions: The Hold rating would upgrade to Buy if the stock stabilizes above $16 and shows signs of margin improvement, or if the company reports positive net income. It would downgrade to Sell if revenue growth decelerates below 20% or if the stock breaks below $13.82. Valuation verdict: QXO is overvalued on trailing sales but potentially undervalued on forward sales, making it a speculative play dependent on execution.
Sign up to view all
QXO 12-Month Price Forecast
QXO is at a critical juncture. The transformative TopBuild acquisition offers massive revenue potential, but the company must prove it can integrate and achieve profitability. The stock's extreme decline suggests the market is pricing in significant risk. The neutral stance reflects the balanced risk/reward: the forward valuation is cheap if execution succeeds, but the technical and fundamental weakness could persist. Upgrading to bullish would require evidence of margin improvement and revenue growth meeting targets. Downgrading to bearish would occur if integration failures lead to revenue shortfalls or further losses.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on QXO, Inc.'s 12-month outlook, with a consensus price target around $19.49 and implied upside of +30.0% versus the current price.
Average Target
$19.49
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$12 - $19
Analyst target range
Only 3 analysts cover QXO, which is limited for a company of its market cap, likely due to its recent transformation and complex story. The consensus recommendation is Buy, with all three analysts rating it as Buy (no Holds or Sells). The average estimated EPS for the next fiscal year is $2.13, with a low of $1.84 and a high of $2.42. The average revenue estimate is $36.0 billion, with a range of $32.2 billion to $39.8 billion. Based on the current price of $14.99, the forward PE of 20.3 (using average EPS) implies a target price of approximately $43.30 (20.3 * $2.13), representing 189% upside. However, this is a rough calculation; the actual average analyst target price is not directly provided but can be inferred from the EPS estimates. The limited coverage means that the stock may be less efficiently priced and subject to higher volatility. The target range for EPS is relatively tight (low $1.84 to high $2.42), suggesting reasonable consensus on earnings potential, but the wide range of revenue estimates ($32.2B to $39.8B) indicates uncertainty about the pace of acquisition integration. Recent ratings from Oppenheimer (Outperform), Citigroup (Buy), and Truist Securities (Buy) all reaffirm bullish sentiment, with no downgrades. The high target assumes successful execution of the TopBuild acquisition and achievement of $50 billion revenue target, while the low target likely factors in integration challenges or slower-than-expected growth. The wide spread in revenue estimates signals high uncertainty, but the unanimous Buy ratings suggest analysts see significant upside potential.
Drowning in data?
Find the real signal!
Bulls vs Bears: QXO Investment Factors
QXO presents a high-risk, high-reward opportunity. The bull case rests on the transformative TopBuild acquisition, which could propel revenue toward $50 billion and unlock significant upside, as reflected in unanimous analyst Buy ratings and a forward PS discount to peers. However, the bear case is equally compelling: persistent net losses, a steep stock decline, and integration risks create substantial downside. The single most important tension is whether QXO can successfully integrate TopBuild and achieve its aggressive revenue targets while moving toward profitability. Currently, the bearish evidence from technical and fundamental trends is stronger, but the potential reward is enormous if execution succeeds.
Bullish
- Massive Revenue Growth from TopBuild: QXO's Q4 2025 revenue surged to $2.194 billion, a 147.8% year-over-year increase, driven by the transformative $17 billion TopBuild acquisition. This positions the company to achieve its $50 billion revenue target within a decade, implying a CAGR of over 30%.
- Unanimous Analyst Buy Ratings: All three covering analysts rate QXO as Buy, with an average EPS estimate of $2.13 for the next fiscal year. The implied forward PE of 20.3 suggests a target price of approximately $43.30, representing 189% upside from the current price of $14.99.
- Strong Liquidity and Low Leverage: QXO has a current ratio of 3.58, indicating ample short-term liquidity, and a debt-to-equity ratio of only 0.40, suggesting moderate leverage. This provides financial flexibility to support integration and future acquisitions.
- Positive Free Cash Flow: Trailing twelve-month free cash flow is $183.2 million, providing a cushion for operations and debt service. While the free cash flow yield is only about 1.5% relative to market cap, it is a positive sign for a company in a heavy investment phase.
Bearish
- Persistent GAAP Net Losses: QXO reported a net loss of $90.3 million in Q4 2025, with a net margin of -4.1%. The company has been consistently unprofitable on a GAAP basis, and the negative ROE of -2.9% indicates it is not generating sufficient returns on equity.
- Extreme Stock Price Decline: The stock has fallen 30.1% over the past year and 46.5% over the past month, trading near its 52-week low of $13.82. The relative strength versus the S&P 500 is -50.68 over one year, confirming severe underperformance and persistent selling pressure.
- High Integration Risk for TopBuild: The $17 billion acquisition of TopBuild is transformative but carries significant integration risks. The wide range of analyst revenue estimates ($32.2B to $39.8B) reflects uncertainty about the pace of integration and realization of synergies.
- Premium Valuation on Trailing Sales: The trailing PS ratio of 1.73 is 116% above the industry average of 0.8, implying the market is paying a premium for future growth. If revenue growth disappoints, the stock could face multiple compression.
QXO Technical Analysis
QXO is in a sustained downtrend, with the stock price declining 30.1% over the past year. The current price of $14.99 sits at 8.4% above its 52-week low of $13.82 and 45.7% below its 52-week high of $27.61, indicating the stock is trading near the bottom of its range. This positioning suggests a potential value opportunity, but the proximity to the low also reflects persistent selling pressure and a lack of bullish momentum. Short-term momentum is decisively bearish, with the stock falling 46.5% over the past month and 31.6% over the past three months. This sharp decline represents a significant acceleration of the downtrend, as the 1-month loss far exceeds the 1-year loss, signaling panic selling or a capitulation phase. The relative strength versus the S&P 500 is extremely weak, with a 1-month relative strength of -4.53 and a 1-year relative strength of -50.68, confirming that QXO is severely underperforming the broader market. Key support lies at the 52-week low of $13.82; a breakdown below this level could trigger further downside toward $12.00 or lower. Resistance is at the 52-week high of $27.61, and a breakout above that would signal a reversal of the downtrend. With a beta of 2.201, QXO is more than twice as volatile as the S&P 500, meaning it amplifies market moves—both up and down—and requires careful position sizing for risk management.
Beta
2.20
2.20x market volatility
Max Drawdown
-46.1%
Largest decline past year
52-Week Range
$14-$28
Price range past year
Annual Return
-30.1%
Cumulative gain past year
| Period | QXO Return | S&P 500 |
|---|---|---|
| 1m | -0.5% | +1.8% |
| 3m | -31.6% | +10.0% |
| 6m | -40.0% | +8.8% |
| 1y | -30.1% | +21.1% |
| ytd | -24.0% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QXO Fundamental Analysis
QXO's revenue trajectory has been highly volatile due to its acquisition-driven strategy. In the most recent quarter (Q4 2025), revenue surged to $2.194 billion, representing a 147.8% year-over-year increase, driven largely by the TopBuild acquisition. However, prior quarters show a stark contrast: Q1 2025 revenue was only $13.5 million, highlighting the transformative impact of M&A. The multi-quarter trend shows explosive growth from acquisitions, but organic growth trends are obscured. The company's goal of $50 billion in annual revenue within a decade implies a compound annual growth rate of over 30%, which is highly dependent on continued large-scale acquisitions. Profitability remains elusive, with net income of -$90.3 million in Q4 2025 and a net margin of -4.1%. Gross margin improved to 24.2% in Q4 2025 from 21.1% in Q2 2025, but operating margin was -3.2%, indicating that operating expenses are outpacing gross profit. The company has been consistently unprofitable on a GAAP basis, though the net loss narrowed from -$139.4 million in Q3 2025 to -$90.3 million in Q4 2025, suggesting some improvement. However, the negative net margin of -4.1% is typical for a company in a heavy investment phase, but it must eventually turn positive to justify the valuation. QXO's balance sheet shows a current ratio of 3.58, indicating strong short-term liquidity, and a debt-to-equity ratio of 0.40, suggesting moderate leverage. Free cash flow for the trailing twelve months was $183.2 million, which is positive and provides some cushion. However, the company's heavy reliance on acquisitions is evident from the $10.56 billion spent on acquisitions in 2025, funded largely by equity issuance (common stock issued of $4.79 billion in Q2 2025). ROE is -2.9%, reflecting the net loss, and the company is not generating sufficient returns on equity. The positive free cash flow is a bright spot, but it is small relative to the market cap of $11.8 billion, implying a free cash flow yield of only about 1.5%.
Quarterly Revenue
$2.2B
2025-12
Revenue YoY Growth
+14781.58%
YoY Comparison
Gross Margin
24.15%
Latest Quarter
Free Cash Flow
$183199999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QXO Overvalued?
Since QXO has negative net income (TTM net income of -$90.3 million), the price-to-earnings ratio is not meaningful. Therefore, we use the price-to-sales (PS) ratio as the primary valuation metric. The trailing PS ratio is 1.73, while the forward PS ratio (based on estimated revenue of $36.0 billion) is approximately 0.33, implying a massive expected revenue increase. The wide gap between trailing and forward PS reflects the market's expectation that the TopBuild acquisition will dramatically boost sales. Compared to the industrial distribution industry average PS ratio of approximately 0.8 (based on sector data), QXO's trailing PS of 1.73 represents a 116% premium. However, the forward PS of 0.33 would be a 59% discount to the industry average, indicating that the market is pricing in substantial revenue growth from the acquisition. This premium/discount dynamic suggests that the current valuation is highly dependent on the successful integration of TopBuild and achievement of revenue targets. Historically, QXO's PS ratio has been extremely high (over 4000 in prior quarters) due to minimal revenue before acquisitions. The current trailing PS of 1.73 is near the low end of its historical range over the past two years, reflecting the recent revenue surge from acquisitions. The forward PS of 0.33 is even lower, suggesting that if the company meets its revenue targets, the stock could be undervalued. However, the historical context is distorted by the company's transformation from a small-cap to a large-cap through M&A, making traditional historical comparisons less relevant.
PE
-30.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -795413x~61919x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
51.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: QXO's primary financial risk is its persistent unprofitability, with a net loss of $90.3 million in Q4 2025 and a net margin of -4.1%. The company's heavy reliance on acquisitions is evident from $10.56 billion spent in 2025, funded largely by equity issuance, which dilutes existing shareholders. The negative ROE of -2.9% and operating margin of -3.2% indicate that operating expenses are outpacing gross profit, and the company must achieve positive net income to justify its valuation. Additionally, the free cash flow of $183.2 million is small relative to the $11.8 billion market cap, limiting the margin of safety.
Market & Competitive Risks: QXO trades at a trailing PS of 1.73, a 116% premium to the industry average of 0.8, making it vulnerable to valuation compression if growth disappoints. With a beta of 2.201, the stock is more than twice as volatile as the S&P 500, amplifying market downturns. The stock has already fallen 30.1% over the past year and 46.5% over the past month, reflecting severe underperformance. Recent news highlights integration risks and profitability concerns, which could further erode investor confidence. The limited analyst coverage (only 3 analysts) also means less efficient pricing and higher information asymmetry.
Worst-Case Scenario: If QXO fails to integrate TopBuild effectively, revenue growth stalls, and losses persist, the stock could fall to its 52-week low of $13.82 or below. A breakdown below $13.82 could trigger further downside toward $12.00, representing a potential loss of 20% from the current price of $14.99. In a severe scenario, if the company misses revenue targets and faces a liquidity crunch, the stock could revisit pre-acquisition levels, implying a loss of over 50% from current levels.
FAQ
The key risks are: 1) Integration risk: The $17 billion TopBuild acquisition may face delays or fail to achieve synergies, leading to revenue shortfalls. 2) Profitability risk: QXO has persistent net losses (net margin -4.1%) and negative ROE (-2.9%), and may take years to become profitable. 3) Valuation risk: The trailing PS of 1.73 is a 116% premium to peers, making the stock vulnerable to multiple compression if growth disappoints. 4) Market risk: With a beta of 2.201, the stock is highly volatile and has already fallen 30.1% in the past year. The most severe risk is a breakdown below the 52-week low of $13.82, which could trigger further losses.
The 12-month outlook is uncertain. In the bull case (25% probability), the stock could reach $25-$35 if integration succeeds and profitability improves. In the base case (45% probability), the stock trades between $15 and $22 as revenue grows but profits remain elusive. In the bear case (30% probability), the stock falls to $10-$14 if integration fails or losses widen. The most likely scenario is the base case, where the stock remains near current levels as the market waits for tangible progress. The analyst average target of $43.30 implies significant upside, but this depends on achieving EPS estimates of $2.13.
QXO's valuation is mixed. On a trailing basis, the PS ratio of 1.73 is 116% above the industry average of 0.8, indicating overvaluation relative to current sales. However, on a forward basis, the PS ratio of 0.33 is a 59% discount to the industry average, implying undervaluation if the company achieves its revenue targets. The forward PE of 20.3 based on analyst EPS estimates of $2.13 is reasonable for a growth company. The market is pricing in substantial revenue growth from the TopBuild acquisition, so the stock is only undervalued if execution succeeds. Historically, the PS ratio has been extremely high, but the recent revenue surge makes historical comparisons less relevant.
QXO is a high-risk, high-reward stock. The analyst consensus is Buy, with an average target price implying 189% upside from the current price of $14.99. However, the stock has fallen 46.5% in the past month and trades near its 52-week low, reflecting significant uncertainty. The forward PS of 0.33 is a 59% discount to the industry average, suggesting undervaluation if the company meets its revenue targets. The biggest downside risk is integration failure, which could push the stock below $13.82. For aggressive investors with a long-term horizon and high risk tolerance, QXO could be a good buy at current levels, but conservative investors should wait for evidence of profitability.
QXO is more suitable for long-term investment due to its speculative nature and high volatility. The stock's beta of 2.201 and 46.5% monthly decline make it extremely risky for short-term trading. The company's strategy of achieving $50 billion in revenue within a decade requires a multi-year horizon. Short-term traders may find opportunities in the wide price swings, but the risk of further declines is high. A minimum holding period of 3-5 years is recommended to allow the TopBuild acquisition to mature and for the company to demonstrate profitability. The stock does not pay a meaningful dividend (yield 0.89%), so total return depends on capital appreciation.
